NinaRuthHorowitzMD
General Surgery • New Haven, CTBreast, Surgical Oncology (Other than Breast)
Assistant Professor, Surgery, Yale University School of Medicine
Dr. Horowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
46 Prince St
Ste 301
New Haven, CT 06519Phone+1 203-562-3577Fax+1 203-782-6864
Education & Training
Yale-New Haven Medical CenterResidency, Surgery, 1979 - 1984
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Certifications & Licensure
CT State Medical License 1983 - 2024
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ Patients.Amelia A Trant, Anees Chagpar, Wei Wei, Veronique Neumeister, David Rimm
Integrative Cancer Therapies. 2022-11-29 - 4 citationsAssociation of Medicaid Expansion with Post-mastectomy Reconstruction Rates.Justin Le Blanc, Mehra Golshan, Donald Lannin, Rachel Greenup, Elizabeth R Berger
Annals of Surgical Oncology. 2022-04-01 - 1 citationsAuthor Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach
NPJ Breast Cancer. 2022-02-03
Press Mentions
Connecticut's Top Doctors 2021: Over 1,500 Physicians in 66 SpecialtiesJune 1st, 2021- Neoadjuvant Durvalumab plus Weekly Nab-Paclitaxel and Dose-Dense doxorubicin/cyclophosphamide in Triple-Negative Breast CancerFebruary 8th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
